Cortisol and 17-Hydroxyprogesterone Kinetics in Saliva after Oral Administration of Hydrocortisone in Children and Young Adolescents with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (original) (raw)

Oral Hydrocortisone Administration in Children with Classic 21-Hydroxylase Deficiency Leads to More Synchronous Joint GH and Cortisol Secretion

Atholl Johnston

The Journal of Clinical Endocrinology & Metabolism, 2002

View PDFchevron_right

Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia

Didier Dewailly

Fertility and Sterility, 2000

View PDFchevron_right

Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Atholl Johnston

Journal of Endocrinology, 2001

View PDFchevron_right

Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets

Thierry Brue

Clinical Pharmacokinetics, 2010

View PDFchevron_right

Effect of Cortisol Treatment on Hormonal Relationships in Congenital Adrenal Hyperplasia

Robert Kelch

Clinical Endocrinology, 1977

View PDFchevron_right

Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia

Claudio Kater

Archives of Disease in Childhood, 1997

View PDFchevron_right

Salivary 17-Hydroxyprogesterone (17-OHP) and Androstenedionein Monitoring Efficacy of Treatment Among Indonesian Congenital Adrenal Hyperplasia Patients

Stenvert Drop

Journal of the ASEAN Federation of Endocrine Societies, 2012

View PDFchevron_right

A phase 2 study of chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia

Lynnette Nieman

The Journal of clinical endocrinology and metabolism, 2015

View PDFchevron_right

Adrenomedullary Function in Patients with Nonclassic Congenital Adrenal Hyperplasia

somya verma

Hormone and Metabolic Research, 2010

View PDFchevron_right

Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency

Irina Bacila

The Journal of Clinical Endocrinology & Metabolism, 2019

View PDFchevron_right

Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets

Kyriakie Sarafoglou

The Journal of Clinical Pharmacology, 2014

View PDFchevron_right

Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-Deoxycortisol in Classic Congenital Adrenal Hyperplasia: Clinical and Hormonal Correlations and Identification of Patients with 11β-Hydroxylase Deficiency among a Large Group with Alleged 21-Hydroxylase Deficiency

Claudio Kater

The Journal of Clinical Endocrinology & Metabolism, 2006

View PDFchevron_right

Variation in serum adrenal hormones in female 21-hydroxylase deficient patients

Mikkel Andreassen

Endocrine Connections

View PDFchevron_right

ADRENAL INSUFFICIENCY: CURRENT THERAPEUTIC REPLACEMENT STRATEGIES. IS THERE ANY EVIDENCE OF IMPROVED CLINICAL OUTCOMES WITH THE USE OF ONCE DAILY LONG ACTING HYDROCORTISONE THERAPY

Mustafa Alabousi

View PDFchevron_right

Assessment of Corticoadrenal Reserve Through Salivary Steroids

Liliana Cruz Contreras

The Endocrinologist, 2002

View PDFchevron_right

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency

L. Ghizzoni, Phyllis Speiser

Clinical Endocrinology, 1998

View PDFchevron_right

Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia

Daniel Margetson

European journal of endocrinology, 2017

View PDFchevron_right

Serum Cortisol and 17-Hydroxyprogesterone Interrelation in Classic 21-Hydroxylase Deficiency: Is Current Replacement Therapy Satisfactory?

Atholl Johnston

The Journal of Clinical Endocrinology & Metabolism, 2001

View PDFchevron_right

MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency

Henrik Falhammar

European journal of endocrinology, 2019

View PDFchevron_right

ADRENARCHE AND GROWTH DURING LHRH AGONIST (LHRHa) ADMINISTRATION

William Crowley

Pediatric Research, 1984

View PDFchevron_right

Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Young-Ah Lee

Journal of Korean medical science, 2011

View PDFchevron_right

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

Phyllis W Speiser

The Journal of Clinical Endocrinology Metabolism, 2013

View PDFchevron_right

The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11beta-hydroxysteroid dehydrogenase activity

John Monson

Clinical Endocrinology, 1998

View PDFchevron_right

BRIEF REPORT Measurement of 18Hydroxycorticosterone during Adrenal Vein Sampling for Primary Aldosteronism

Richard Auchus

2010

View PDFchevron_right

21Hydroxylase–deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study

Carlos Morán

American Journal of Obstetrics and Gynecology, 2000

View PDFchevron_right

Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers

Warrick Inder

BMC endocrine disorders, 2014

View PDFchevron_right